Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers
Open Access
- 1 November 1984
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 26 (5) , 757-761
- https://doi.org/10.1128/aac.26.5.757
Abstract
Twelve male subjects, aged 19 to 40 years, shown to be healthy by examination and laboratory tests, took 500 mg of ciprofloxacin every 12 h for 7 days. After the first and the last dose, blood and urine samples were taken and drug concentrations were determined by bioassay. There was a significant buildup in mean concentrations in serum from day 1 to day 7; mean peak levels (attained after 1 to 2 h) were 1.9 and 2.8 micrograms/ml, respectively. The terminal half-life was 3.5 to 4 h. About 40% of the drug was excreted into the urine during the 12-h period after dosing; minimum mean concentrations in urine were 105 micrograms/ml on day 1 and 174 micrograms/ml on day 7. Considerable amounts of ciprofloxacin were found in the feces on day 7 (185 to 2,220 micrograms/g). Marked changes in the aerobic part of the fecal flora were observed as a result of taking ciprofloxacin: coliforms were absent on day 7, and concentrations of streptococci and staphylococci were significantly reduced. There was no overgrowth by yeasts. One week later the fecal flora had returned to a state similar to that found before treatment. Anaerobes were little affected quantitatively but acquired resistance to ciprofloxacin. Side effects were mild and transient.This publication has 10 references indexed in Scilit:
- Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humansAntimicrobial Agents and Chemotherapy, 1984
- In-vitro studies with ciprofloxacin, a new 4-quinolone compoundJournal of Antimicrobial Chemotherapy, 1984
- The pharmacokinetics and tissue penetration of norfloxacinJournal of Antimicrobial Chemotherapy, 1984
- Pharmacokinetics and tissue penetration of ciprofloxacinAntimicrobial Agents and Chemotherapy, 1983
- In vitro activity of ciprofloxacin (Bay o 9867)Antimicrobial Agents and Chemotherapy, 1983
- In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1983
- Colonization resistance of the digestive tract: clinical consequences and implicationsJournal of Antimicrobial Chemotherapy, 1982
- Rifaprim (rifampicin plus trimethoprim): Pharmacokinetics and effects on the normal flora of manBiopharmaceutics & Drug Disposition, 1981
- Transport and Storage of Faeces for Bacteriological ExaminationJournal of Applied Bacteriology, 1971
- TREATMENT OF URINARY-TRACT INFECTIONS WITH AMPICILLIN A Clinical TrialThe Lancet, 1962